The nigrostriatal system in Parkinson's disease
- PMID: 1978514
The nigrostriatal system in Parkinson's disease
Abstract
Patterns of dopaminergic cell loss in the midbrain and patterns of mesostriatal fiber loss in the caudate nucleus and putamen are described for cases of idiopathic Parkinson's disease. Neither cell loss nor fiber loss is homogeneous. In the midbrain, quantitative analysis points to a selective vulnerability of neurons in the most heavily pigmented dopaminergic cell groups. In the striatum, a dorsolateral-to-ventromedial gradient of loss appears to characterize both the caudate nucleus and the putamen. These patterns of loss and sparing have implications both for analysis of the clinical symptoms of Parkinson's disease and for study of the etiology of this disease.
Similar articles
-
Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms.Adv Neurol. 1993;60:140-7. Adv Neurol. 1993. PMID: 8420131 Review. No abstract available.
-
[Neurobiologic and pharmacologic studies on the pathogenesis of Parkinson disease].Wien Med Wochenschr. 1986 Aug 31;136(15-16):401-8. Wien Med Wochenschr. 1986. PMID: 2878540 German.
-
Second messenger systems in brains of patients with Parkinson's or Huntington's disease.Adv Neurol. 1993;60:175-80. Adv Neurol. 1993. PMID: 8093576
-
Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.Ann Neurol. 1995 Feb;37(2):265-72. doi: 10.1002/ana.410370219. Ann Neurol. 1995. PMID: 7847868
-
Pathogenesis and animal studies of Parkinson's disease.Curr Opin Neurol Neurosurg. 1993 Jun;6(3):323-32. Curr Opin Neurol Neurosurg. 1993. PMID: 8507901 Review.
Cited by
-
Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein.NPJ Parkinsons Dis. 2022 May 24;8(1):61. doi: 10.1038/s41531-022-00322-x. NPJ Parkinsons Dis. 2022. PMID: 35610264 Free PMC article.
-
Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2.J Cell Sci. 2009 Sep 15;122(Pt 18):3385-92. doi: 10.1242/jcs.053124. Epub 2009 Aug 25. J Cell Sci. 2009. PMID: 19706677 Free PMC article.
-
Striosomal arrangement of met-enkephalin and substance P expression in parkinsonism-dementia complex on Guam.Acta Neuropathol. 1993;85(4):390-3. doi: 10.1007/BF00334449. Acta Neuropathol. 1993. PMID: 7683167
-
In vivo evidence for the unique kinetics of evoked dopamine release in the patch and matrix compartments of the striatum.Anal Bioanal Chem. 2021 Nov;413(27):6703-6713. doi: 10.1007/s00216-021-03300-z. Epub 2021 Apr 12. Anal Bioanal Chem. 2021. PMID: 33843017 Free PMC article.
-
Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils.Neurobiol Dis. 2019 Oct;130:104525. doi: 10.1016/j.nbd.2019.104525. Epub 2019 Jul 2. Neurobiol Dis. 2019. PMID: 31276792 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical